Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.

Hauser SL, Kappos L, Montalban X, Craveiro L, Chognot C, Hughes R, Koendgen H, Pasquarelli N, Pradhan A, Prajapati K, Wolinsky JS.